Boris Tichý

2.4k citations

44 papers · 1.0k indexed · h-index 14

Impact in

Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Pathology and Forensic Medicine top 5%
- Lymphoma Diagnosis and Treatment

Papers in

Genetics 23
- Chronic Lymphocytic Leukemia Research 21
Pathology and Forensic Medicine 15
- Lymphoma Diagnosis and Treatment 13

Co-authors: Šárka Pospı́šilová Michael Doubek Jiřı́ Mayer Yvona Brychtová Jitka Malčíková Martin Trbušek Karla Plevová Šárka Pavlová
Journals: Blood (7 papers)Leukemia (3 papers)Experimental Hematology (2 papers)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2 papers)Biochemical Pharmacology (2 papers)
Partner nations: Czechia Austria United States

In The Last Decade

Boris Tichý

44 papers receiving 1.0k citations

Peers

Countries citing papers authored by Boris Tichý

Since Specialization

Citations

This map shows the geographic impact of Boris Tichý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Tichý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Tichý more than expected).

Fields of papers citing papers by Boris Tichý

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Tichý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Tichý. The network helps show where Boris Tichý may publish in the future.

Co-authors

The 25 scholars most cited alongside Boris Tichý, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Boris Tichý Line = papers co-authored together Boris Tichý links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—2024 update Leukemia ·Jitka Malčíková, Šárka Pavlová, Panagiotis Baliakas, Thomas Chatzikonstantinou, Eugen Tausch, Mark Catherwood, Francesca Maria Rossi, Thierry Soussi, Boris Tichý, Arnon P. Kater, Carsten Utoft Niemann, Frédéric Davi, Gianluca Gaïdano, Stephan Stilgenbauer, Richard Rosenquist, Κώστας Σταματόπουλος, Paolo Ghia, Šárka Pospı́šilová	2024	8
2	Cell Tree Rings: the structure of somatic evolution as a human aging timer GeroScience ·Attila Csordás, Botond Sipos, Terézia Kurucová, Andrea Volfova, Frantisek Zamola, Boris Tichý, D. G. Hicks	2024	1
3	Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single‐cell RNA sequencing Molecular Oncology ·Terézia Kurucová, Kamila Réblová, Pavlína Janovská, Jakub Paweł Porc, Veronika Navrkalová, Šárka Pavlová, Jitka Malčíková, Karla Plevová, Boris Tichý, Michael Doubek, Vı́tězslav Bryja, Jana Kotašková, Šárka Pospı́šilová	2024	1
4	EGFR stimulation enables IL-6 trans-signalling via iRhom2-dependent ADAM17 activation in mammary epithelial cells Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Neele Schumacher, Ilka Thomsen, Florian Brundert, Václav Hejret, Stefan Düsterhöft, Boris Tichý, Dirk Schmidt‐Arras, Matthias Voß, Stefan Rose‐John	2023	5
5	Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options Blood ·Jitka Malčíková, Šárka Pavlová, Barbara Vonková, Lenka Radová, Karla Plevová, Jana Kotašková, Karol Pál, Barbara Dvořáčková, Marcela Ženatová, Jakub Hynšt, Eva Ondroušková, Anna Panovská, Yvona Brychtová, Kristýna Závacká, Boris Tichý, Nikola Tom, Jiřı́ Mayer, Michael Doubek, Šárka Pospı́šilová	2021	24
6	Testing of library preparation methods for transcriptome sequencing of real life glioblastoma and brain tissue specimens: A comparative study with special focus on long non-coding RNAs PLoS ONE ·Marek Večeřa, Jiří Šáňa, Jan Oppelt, Boris Tichý, Alena Kopková, Radim Lipina, Martin Smrčka, Radim Jančálek, Markéta Hermanová, Leoš Křen, Ondřej Slabý	2019	6
7	Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status Leukemia ·Blanka Kubešová, Šárka Pavlová, Jitka Malčíková, Jitka Kabáthová, Lenka Radová, Nikola Tom, Boris Tichý, Karla Plevová, Barbara Kantorová, Kristýna Fiedorová, Martina Slavíková, Vojtěch Bystrý, Jarmila Kissová, Bettina Gisslinger, Heinz Gisslinger, Miroslav Penka, Jiřı́ Mayer, Róbert Královics, Šárka Pospı́šilová, Michael Doubek	2017	49
8	Trypanosomatid mitochondrial RNA editing: dramatically complex transcript repertoires revealed with a dedicated mapping tool Nucleic Acids Research ·Evgeny S. Gerasimov, A. A. Gasparyan, Iosif Kaurov, Boris Tichý, Maria D. Logacheva, Alexander Kolesnikov, Julius Lukeš, Vyacheslav Yurchenko, Sara L. Zimmer, Pavel Flegontov	2017	27
9	GLASS: assisted and standardized assessment of gene variations from Sanger sequence trace data Bioinformatics ·Karol Pál, Vojtěch Bystrý, Tomáš Reigl, Martin Demko, Adam Krejčí, Tasoula Touloumenidou, Evangelia Stalika, Boris Tichý, Paolo Ghia, Κώστας Σταματόπουλος, Šárka Pospı́šilová, Jitka Malčíková, Nikos Darzentas	2017	8
10	Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia Leukemia ·Jitka Malčíková, Kateřina Staňo Kozubík, Boris Tichý, Barbara Kantorová, Šárka Pavlová, Nikola Tom, Lenka Radová, Jana Šmardová, Filip Pardy, Michael Doubek, Yvona Brychtová, Marek Mráz, Karla Plevová, Eva Divíšková, Alexandra Oltová, Jiřı́ Mayer, Šárka Pospı́šilová, Martin Trbušek	2014	106
11	TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods Tumor Biology ·Barbara Kantorová, Jitka Malčíková, Jana Šmardová, Šárka Pavlová, Martin Trbušek, Nikola Tom, Karla Plevová, Boris Tichý, Sim Truong, Eva Divíšková, Jana Kotašková, Alexandra Oltová, Nancy Patten, Yvona Brychtová, Michael Doubek, Jiřı́ Mayer, Šárka Pospı́šilová	2014	9
12	The Planar Cell Polarity Pathway Drives Pathogenesis of Chronic Lymphocytic Leukemia by the Regulation of B-Lymphocyte Migration Cancer Research ·Markéta Kaucká, Karla Plevová, Šárka Pavlová, Pavlína Janovská, Archana Mishra, Jan Verner, Jiřina Procházková, Pavel Krejčı́, Jana Kotašková, Petra Ovesná, Boris Tichý, Yvona Brychtová, Michael Doubek, Alois Kozubı́k, Jiří Mayer, Šárka Pospı́šilová, Vı́tězslav Bryja	2013	82
13	Mesalamine modulates intercellular adhesion intercellularadhesion through inhibition of p-21 activated kinase-1 Biochemical Pharmacology ·Vineeta Khare, Alex Lyakhovich, Kyle Dammann, Molly Lang, M. Borgmann, Boris Tichý, Šárka Pospı́šilová, Genna M. Luciani, Ch. Campregher, Rayko Evstatiev, Maren Pflueger, H. Hundsberger, Ch. Gasché	2013	6
14	The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus Leukemia Research ·Marek Mráz, Kateřina Staňo Kozubík, Karla Plevová, Kateřina Musilová, Boris Tichý, Marek Borský, Petr Kuglík, Michael Doubek, Yvona Brychtová, Jiřı́ Mayer, Šárka Pospı́šilová	2013	11
15	Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia Annals of Hematology ·Marta Krejčí, Michael Doubek, Yvona Brychtová, Olga Stehlíková, Jana Chovancová, Boris Tichý, Hana Skuhrová Francová, Milan Navrátil, Miroslav Tomíška, Ondřej Horký, Šárka Pospı́šilová, Jiřı́ Mayer	2012	6
16	A real-time (PCR) for a real life…? Quantitative evaluation of BCL2/IGH in follicular lymphoma and its implications for clinical practice Experimental Hematology ·Andrea Janíková, Andrea Marečková, Dana Dvořáková, Zbyněk Bortlíček, Boris Tichý, Milan Navrátil, Zdeněk Král, Šárka Pospı́šilová, Jiřı́ Mayer	2012	3
17	Gene expression profiling of acute graft-vs-host disease after hematopoietic stem cell transplantation Experimental Hematology ·Jan Verner, Jitka Kabáthová, Alexandra Tomancová, Šárka Pavlová, Boris Tichý, Marek Mráz, Yvona Brychtová, Marta Krejčí, Zbyněk Zdráhal, Martin Trbušek, Jana Volejníková, Petr Sedláček, Michael Doubek, Jiřı́ Mayer, Šárka Pospı́šilová	2012	6
18	Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1 Biochemical Pharmacology ·Vineeta Khare, Alex Lyakhovich, Kyle Dammann, Michaela Lang, Melanie Borgmann, Boris Tichý, Šárka Pospı́šilová, Gloria Luciani, Christoph Campregher, Rayko Evstatiev, Maren Pflueger, Harald Hundsberger, Christoph Gasché	2012	42
19	High Expression of Lymphocyte-Activation Gene 3 (LAG3) in Chronic Lymphocytic Leukemia Cells Is Associated with Unmutated Immunoglobulin Variable Heavy Chain Region (IGHV) Gene and Reduced Treatment-Free Survival Journal of Molecular Diagnostics ·Jana Kotašková, Boris Tichý, Martin Trbušek, Hana Skuhrová Francová, Jitka Kabáthová, Jitka Malčíková, Michael Doubek, Yvona Brychtová, Jiřı́ Mayer, Šárka Pospı́šilová	2010	38
20	Identification of somatic hypermutations in the TP53 gene in B-cell chronic lymphocytic leukemia Molecular Immunology ·Jitka Malčíková, Jana Šmardová, Šoňa Peková, Soňa Čejková, Jana Kotašková, Boris Tichý, Hana Skuhrová Francová, Michael Doubek, Yvona Brychtová, Daniela Janek, Šárka Pospı́šilová, Jiřı́ Mayer, D. Dvořáková, Martin Trbušek	2007	10

About Boris Tichý

Boris Tichý is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Cancer Research and Oncology, having authored 44 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (21 papers), Lymphoma Diagnosis and Treatment (13 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Cancer-related Molecular Pathways (6 papers), Advanced Breast Cancer Therapies (5 papers), MicroRNA in disease regulation (4 papers), Single-cell and spatial transcriptomics (3 papers) and Galectins and Cancer Biology (3 papers). The work is most often cited by research in Genetics (435 citations), Pathology and Forensic Medicine (266 citations), Cancer Research (178 citations), Immunology (195 citations) and Oncology (221 citations). Boris Tichý has collaborated with scholars based in Czechia, Austria and United States. Frequent co-authors include Šárka Pospı́šilová, Michael Doubek, Jiřı́ Mayer, Yvona Brychtová, Jitka Malčíková, Martin Trbušek, Karla Plevová, Šárka Pavlová, Aleš Hampl and Hana Skuhrová Francová. Their work appears in journals such as Blood, Leukemia, Experimental Hematology, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact